Roche's Genome Analysis Sales Slide 21 Percent YTD
October 16, 2012
Roche's Genome Analysis Sales Slide 21 Percent YTD
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In Applied Science Restructuring, Roche Exits Microarrays, Bundles 'Sequencing Solutions,' R&D
June 12, 2012 / In Sequence - Roche Achieves Sequencing on Semiconductor Platform; Automating ePCR with Japanese Partner
January 22, 2013 / In Sequence - IRON-II Study Uses 454 Sequencing to Investigate New Markers for Hematological Malignancies
September 12, 2012 / Clinical Sequencing News - MLL Developing RainDance, MiSeq Gene Panel for Myeloid Malignancies
August 15, 2012 / Clinical Sequencing News - Roche Diagnostics up 5 Percent in H1 2012, MDx up 6 Percent
July 26, 2012 / GenomeWeb Daily News